Table 3.
No. | First Author, Publication Year | Was the Studied Cancer Cell Line(s) Reported? | Was the Duration of Exposure to the Studied miR to Tumoral Cells Reported? | Was the ConCentration of the Studied miR Reported? | Was a Standard Culture Media Used for the Study? | Were Reliable Tools Used to Assess the Outcome? | Were the Experiments Conducted More than Once? | Was More than One Independent Experiment Performed? | The Overall Risk of Bias |
---|---|---|---|---|---|---|---|---|---|
1 | Narges Dastmalchi, 2021 [30] | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias |
2 | Katayoun Bahman Soufiani, 2021 [31] | Without bias | Without bias | With bias | Without bias | Without bias | Without bias | Without bias | Low-bias |
3 | Mina Rasoolnezhad, 2021 [32] | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias |
4 | Li-Li Wang, 2020 [13] | Without bias | Without bias | With bias | Without bias | Without bias | Without bias | Without bias | Low-bias |
5 | Fu Peng, 2020 [33] | Without bias | With bias | With bias | Without bias | Without bias | Without bias | Without bias | Low-bias |
6 | Narges Dastmalchi, 2020 [34] | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias |
7 | Shirin Azarbarzin, 2021 [35] | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias |
8 | Lianzhou Yang, 2018 [38] | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias | Without bias |
9 | Xiaojia Huang, 2017 [6] | Without bias | Without bias | With bias | Without bias | Without bias | Without bias | Without bias | Low-bias |